Inhibitors and stimulators of lysosome-phagosome fusion
Mozhenok, T.P.; Bulychev, A.G.; Braun, A.D.
Voprosy Meditsinskoi Khimii 36(6): 11-13
1990
ISSN/ISBN: 0042-8809 PMID: 2075711 Document Number: 354573
Document emailed within 1 workday
Related Documents
Vesole, D.H.; Goust, J.M.; Fett, J.W.; Fudenberg, H.H. 1979: Stimulators and inhibitors of lymphocyte DNA synthesis in supernatants from human lymphoid cell lines Journal of Immunology 123(3): 1322-1328Otaki, N. 1970: Melanosome and lysosome. II. Digestion of melanosome with mouse liver lysosome Bulletin of Tokyo Medical and Dental University 17(3): 179-186
Goebel, F.D. 2004: Fusion inhibitors. one year therapy with T-20--initial evaluation MMW Fortschritte der Medizin 146(Special Issue 1): 42-43
Koopmans, P.P. 2003: Enfuvirtide, the first representative of a new class of drugs for the treatment of HIV infection : HIV fusion inhibitors Nederlands Tijdschrift Voor Geneeskunde 147(36): 1726-1729
Swanson, M.S.; Isberg, R.R. 1993: Formation of the Legionella pneumophila replicative phagosome Infectious Agents and Disease 2(4): 224-226
Laumonier, R.; Marche, C.; Metayer, J. 1971: The lysosome in pathology Annales d'Anatomie Pathologique 16(3): 321-333
Long, H.; Kazunasa, U.; Liu, S.; Akio, S.; Taito, I. 2007: Preliminary application of one-level posterior lumbar interbody fusion with prospace and facet fusion using local autograft Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 21(11): 1155-1159
Korovkin, B.F.; Gosudarskiĭ, V.I.; Zaitseva, K.K.; Ivin, B.A.; Ipatova, L.P. 1980: Liposomes and cAMP in lysosome membrane stabilization Voprosy Meditsinskoi Khimii 26(3): 403-406
Galante Romo, M.ía.I.; Ciappara Paniagua, M.; Moreno Sierra, J.ús. 2019: Fusion biopsy. Analysis of fusion software platforms Archivos Espanoles de Urologia 72(8): 794-803
Leufvén, C.; Nordwall, A. 1999: Management of chronic disabling low back pain with 360 degrees fusion. Results from pain provocation test and concurrent posterior lumbar interbody fusion, posterolateral fusion, and pedicle screw instrumentation in patients with chronic disabling low back pain Spine 24(19): 2042-2045
Kim, N.H.; Lee, J.W. 1999: Anterior interbody fusion versus posterolateral fusion with transpedicular fixation for isthmic spondylolisthesis in adults. A comparison of clinical results Spine 24(8): 812
Lukash, A.I.; Chikhachev, A.S.; Kartashova, L.D. 1975: Lysosome enzymes of brain in hyperoxia and under the effect of urea Ukrains'kyi Biokhimichnyi Zhurnal 47(6): 728-733
Maianskaia, N.N.; Panin, L.E.; Filatova, T.G. 1984: Lysosome participation in the recovery processes in the liver following physical loading Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1984(4): 65-70
Fukuda, M. 1990: Lysosomal membrane glycoproteins; structure, biosynthesis, and trafficking to lysosome SEIKAGAKU. Journal of Japanese Biochemical Society 62(10): 1225-1240
Aleksandrowicz, J.; Starek, A.; Moszczyński, P.; Czarnobilski, Z. 1978: Changes in the activity of lysosome beta-glucuronidase in rat leukocytes treated with various doses of selenium Patologia Polska 29(2): 143-151
Mego, J.L. 1985: The stimulatory effect of glutathione on proteolysis in mouse kidney lysosome suspensions Progress in Clinical and Biological Research 180: 487-489
Harvey, S.R.; Mirand, E.A.; Back, N.; Murphy, G.P. 1972: In vitro generation of erythropoietic activity by the lysosome-rich fraction of rat kidneys Journal of Medicine 3(6): 333-340
Tsilli, E.I.; Titova, V.G.; Kondakova, A.E.; Korolenko, T.A. 1973: Change in lysosome membrane permeability in the rat liver under the action of different harmful factors Farmakologiia i Toksikologiia 36(5): 724-727
Zhu, Y.; Liu, H-ying.; Wang, B.; Wang, H-min.; Qian, Y-long.; Zhu, Z-qi.; Miao, K-nan. 2013: Long-term clinical outcomes of selective segmental transforaminal lumbar interbody fusion and posterior spinal fusion for degenerative lumbar scoliosis Zhonghua Yi Xue Za Zhi 93(45): 3577-3581
Ohgimoto, S.; Tabata, N.; Suga, S.; Nishio, M.; Ohta, H.; Tsurudome, M.; Komada, H.; Kawano, M.; Watanabe, N.; Ito, Y. 1995: Molecular characterization of fusion regulatory protein-1 (FRP-1) that induces multinucleated giant cell formation of monocytes and HIV gp160-mediated cell fusion. FRP-1 and 4F2/CD98 are identical molecules Journal of Immunology 155(7): 3585-3592